Detalhe da pesquisa
1.
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
J Viral Hepat;
30(4): 335-344, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36601668
2.
The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease.
Aliment Pharmacol Ther;
57(12): 1417-1422, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36967586
3.
Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women.
Int J Gen Med;
16: 4393-4404, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37789881
4.
Post-Acute SARS-CoV-2 Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute Infection.
Int J Gen Med;
16: 1479-1490, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37123886
5.
Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease.
JAMA Netw Open;
4(9): e2123923, 2021 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34529067
6.
Treatment regimens for non-alcoholic fatty liver disease.
Ann Hepatol;
8 Suppl 1: S51-9, 2009.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19381125
7.
The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment.
Therap Adv Gastroenterol;
8(5): 298-312, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26327920